JNJ-40646527

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNJ-40646527
Drug Alias NameCSF-1R inhibitors (Janssen Pharmaceuticals)JNJ-40646527
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage Colony Stimulating Factor 1 inhibitors
TargetsMacrophage Colony Stimulating Factor 1
Therapy Area/IndicationsHodgkin Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHodgkin Disease

Other Information

ATC CodeN/A
Related LinksN/A